Insulin, Opioids Warrant Vigilance as High Harm Drugs
Report on presentations by ISMP staff at the American Society of Health-System Pharmacists (ASHP) 2017 Midyear Clinical Meeting that focused on errors associated with the high-alert medications insulin and opioids. ISMP’s Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults are discussed. For the full text of the article, visit the Pharmacy Practice News website. Please note that access may require free registration.